SARS-CoV-2 elimination, not mitigation, creates best outcomes for health, the economy, and civil liberties

Miquel Oliu-barton; Bary S R Pradelski; Philippe Aghion; Patrick Artus; Ilona Kickbusch; Jeffrey V Lazarus; Devi Sridhar; Samantha Vanderslott

doi:10.1016/S0140-6736(21)00978-8

SARS-CoV-2 elimination, not mitigation, creates best outcomes for health, the economy, and civil liberties

Miquel Oliu-barton, Bary S R Pradelski, Philippe Aghion, Patrick Artus, Ilona Kickbusch, Jeffrey V Lazarus, Devi Sridhar, Samantha Vanderslott

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English
Journal	The Lancet
DOIs	https://doi.org/10.1016/S0140-6736(21)00978-8
Publication status	Published - 28 Apr 2021

Access to Document

10.1016/S0140-6736(21)00978-8

SARS-CoV-2 elimination, not mitigation, creates best outcomes for health, the economy, and civil libertiesAccepted author manuscript, 210 KBLicence: Creative Commons: Attribution-NonCommercial-NoDerivatives (CC BY-NC-ND)

https://linkinghub.elsevier.com/retrieve/pii/S0140673621009788

Cite this

@article{c7e4e2ae9f674d4ab34b98435f9a60cd,

title = "SARS-CoV-2 elimination, not mitigation, creates best outcomes for health, the economy, and civil liberties",

author = "Miquel Oliu-barton and Pradelski, \{Bary S R\} and Philippe Aghion and Patrick Artus and Ilona Kickbusch and Lazarus, \{Jeffrey V\} and Devi Sridhar and Samantha Vanderslott",

year = "2021",

month = apr,

day = "28",

doi = "10.1016/S0140-6736(21)00978-8",

language = "English",

journal = "The Lancet",

issn = "0140-6736",

publisher = "Elsevier",

}

TY - JOUR

T1 - SARS-CoV-2 elimination, not mitigation, creates best outcomes for health, the economy, and civil liberties

AU - Oliu-barton, Miquel

AU - Pradelski, Bary S R

AU - Aghion, Philippe

AU - Artus, Patrick

AU - Kickbusch, Ilona

AU - Lazarus, Jeffrey V

AU - Sridhar, Devi

AU - Vanderslott, Samantha

PY - 2021/4/28

Y1 - 2021/4/28

U2 - 10.1016/S0140-6736(21)00978-8

DO - 10.1016/S0140-6736(21)00978-8

M3 - Comment/debate

SN - 0140-6736

JO - The Lancet

JF - The Lancet

ER -